Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Cho

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Plos One|July 14, 2012
Loss of BRCA1-A complex function in RAP80 null tumor cellsChunjing Bian, Rong Wu, Kathleen Cho, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 17, 2016
New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal disseminationLan G Coffman, Daniela Burgos-Ojeda, Rong Wu, et al.
Nature|October 28, 2015
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapyDongjun Peng, Ilona Kryczek, Nisha Nagarsheth, et al.
Immunity|September 10, 2013
Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2Tracy X Cui, Ilona Kryczek, Lili Zhao, et al.
Iscience|January 5, 2026
High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human diseaseLudmila Szabova, Lucy Lu, Melanie B Gordon, et al.
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Plos One|July 14, 2012
Loss of BRCA1-A complex function in RAP80 null tumor cellsChunjing Bian, Rong Wu, Kathleen Cho, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 17, 2016
New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal disseminationLan G Coffman, Daniela Burgos-Ojeda, Rong Wu, et al.
Nature|October 28, 2015
Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapyDongjun Peng, Ilona Kryczek, Nisha Nagarsheth, et al.
Immunity|September 10, 2013
Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2Tracy X Cui, Ilona Kryczek, Lili Zhao, et al.
Iscience|January 5, 2026
High-grade serous ovarian cancer induced in different sites of origin in mice exemplifies diverse features of the human diseaseLudmila Szabova, Lucy Lu, Melanie B Gordon, et al.
Gynecologic Oncology|November 15, 2021
Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer associationLilah Khoja, Rachel Palmieri Weber, , et al.
Pageof 1